FTC allows Amgen’s $28B deal for Horizon to go through, with conditions September 1, 2023 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on FTC allows Amgen’s $28B deal for Horizon to go through, with conditions The settlement between Amgen and the FTC is may reassure those in the industry who feared a more activist regulator would gum up dealmaking. Click here to view original post